Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders
Clinical & Experimental Allergy · 2024
DOI: 10.1111/cea.14518 ↗At a glance
Journal article in Clinical & Experimental Allergy, 2024. Written by Mutong Zhao and 4 co-authors. Institution: Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. Major MEDLINE topics: Antibodies, Monoclonal, Humanized, Dermatitis, Atopic. Cited 6 times so far (Crossref); 9 references. Funded by: Capital's Fund for Health Improvement and Research, Chinese Association of Rehabilitation Medicine's Fund for Technological Improvement, Beijing Natural Science Foundation.
Abstract (original language)
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
ORCID profiles: Mutong Zhao
Funding
- Capital's Fund for Health Improvement and Research
- Chinese Association of Rehabilitation Medicine's Fund for Technological Improvement
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Cite
APA
Zhao, M., Zhuang, Y., Liang, Y., Ma, L., & Shen, C. (2024). Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14518
Vancouver
Zhao M, Zhuang Y, Liang Y, Ma L, Shen C. Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders. Clinical & Experimental Allergy. 2024. doi:10.1111/cea.14518
BibTeX
@article{Zhao2024,
author = {Zhao, Mutong and Zhuang, Yi and Liang, Yuan and Ma, Lin and Shen, Chunping},
title = {Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders},
journal = {Clinical & Experimental Allergy},
year = {2024},
doi = {10.1111/cea.14518}
}
EUVIMED